FY2018 EPS Estimates for Aethlon Medical, Inc. Lifted by Zacks Investment Research (AEMD)

Aethlon Medical, Inc. (NASDAQ:AEMD) – Investment analysts at Zacks Investment Research boosted their FY2018 EPS estimates for Aethlon Medical in a research note issued to investors on Wednesday. Zacks Investment Research analyst B. Marckx now anticipates that the medical equipment provider will earn ($0.56) per share for the year, up from their prior estimate of ($0.57).

Aethlon Medical (NASDAQ:AEMD) last released its earnings results on Thursday, November 2nd. The medical equipment provider reported ($0.14) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.16) by $0.02.

WARNING: This piece was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://ledgergazette.com/2017/11/15/fy2018-eps-estimates-for-aethlon-medical-inc-lifted-by-zacks-investment-research-aemd.html.

Separately, ValuEngine upgraded shares of Aethlon Medical from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st.

Aethlon Medical (AEMD) traded up $0.03 during trading on Monday, reaching $0.95. 163,300 shares of the company’s stock were exchanged, compared to its average volume of 198,650. Aethlon Medical has a 12 month low of $0.79 and a 12 month high of $5.17. The company has a current ratio of 2.97, a quick ratio of 2.97 and a debt-to-equity ratio of 78.00.

Aethlon Medical Company Profile

Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.

Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply